Lene Uhrbom

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 17, 2024
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers.

Helene Damhofer, Tülin Tatar, Benjamin Southgate

|Apr 26, 2022
Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival.

Xi Lu, Naga Prathyusha Maturi, Malin Jarvius

|Dec 24, 2019
A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures.

Naga Prathyusha Maturi, E-Jean Tan, Yuan Xie

|Nov 23, 2019
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells.

Matko Čančer, Lisa F Drews, Johan Bengtsson

|Oct 26, 2018
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.

Yuan Xie, Anders Sundström, Naga P Maturi

Pageof 1

Frequent Collaborators

2 joint publications

E-Jean Tan

2 joint publications

Naga Prathyusha Maturi

1 joint publications

Matko Čančer

1 joint publications

Sara Bolin